CP
HUMA icon

CenterBook Partners’s Humacyte HUMA Stock Holding History

CenterBook Partners’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-283,627
Closed -$494K – 613
2025
Q3 		$494K Sell
283,627
-3,146,628
-92% -$6.16M 0.02% 482
2025
Q2 		$7.17M Buy
3,430,255
+2,007,743
+141% +$3.86M 0.4% 56
2025
Q1 		$2.43M Buy
1,422,512
+142,673
+11% +$536K 0.15% 170
2024
Q4 		$6.46M Buy
+1,279,839
New +$6.33M 0.39% 77
2022
Q3 		– Sell
-41,470
Closed -$133K – 416
2022
Q2 		$133K Sell
41,470
-4,282
-9% -$23.8K 0.03% 370
2022
Q1 		$323K Buy
45,752
+22,046
+93% +$128K 0.12% 277
2021
Q4 		$172K Buy
+23,706
New +$234K 0.1% 272

Other funds holding HUMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return